Genaera, I don't believe has the technology to deliver the squalamine intranasally, but either a partner would, or they license a technology from a bently pharamaceuticals, or a company like that.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.